Sarepta Therapeutics Helps Biotech ETFs Buck Market Trend
Biotechnology sector-related exchange traded funds were among the few areas of the markets that shook off the tariffs-talk volatility and was still…
XBI
6 Top Healthcare ETFs Rally as Trump Vows End to ‘Global Freeloading’
Healthcare stocks and top healthcare ETFs rallied Friday after President Donald Trump vowed to end to “global freeloading” that has allowed foreign…
Catalysts Abound for Biotech ETFs
Biotechnology stocks and biotech ETFs tumbled in the back half of March and to start April. For example, the SPDR S&P Biotech…
Alkermes FDA Refusal: Biotech ETFs Dragged Down
Biotechnology stocks and biotech ETFs were among the worst performing areas of the markets Monday as Alkermes (NasdaqGS: ALKS) shares plunged after…
Healthcare Dip Could be a Buying Opportunity
The Health Care Select Sector SPDR (NYSEArca: XLV), the largest exchange traded fund dedicated to the S&P 500’s third-largest sector weight, tumbled…
Biotech ETFs Pop on Celgene, Juno Deal
Biotechnology sector-related ETFs surged Monday after Celgene (NasdaqGS: CELG) said it will acquire Juno Therapeutics (NasdaqGS: JUNO) to expand its cancer treatment…
Biotech Slump Could be a Buying Opportunity
Biotechnology stocks and ETFs are slumping in the fourth quarter. For example, the iShares Nasdaq Biotechnology ETF (NASDAQGM: IBB), the largest biotech ETF…
Biotech Decline Could be a Buying Opportunity
The iShares Nasdaq Biotechnology ETF (NASDAQGM: IBB), the largest biotech ETF by assets, and its equal-weight rival, the SPDR S&P Biotech ETF (NYSEArca:…
Why Healthcare Sector is a Great November Play
It is already the second-best sector this year behind technology, but the healthcare sector has a penchant for performing well in November.…
Hot Biotech Stocks, ETFs Can Keep Surging
The iShares Nasdaq Biotechnology ETF (NASDAQGM: IBB), the largest biotech ETF by assets, and its equal-weight rival, the SPDR S&P Biotech ETF (NYSEArca:…
Bullish Biotech Bets After Positive Attention
Biotechnology ETFs have been getting plenty of positive attention in recent weeks, a trend that certainly extends to the SPDR S&P Biotech…
A Good Time to Own Biotech ETFs
The SPDR S&P Biotech ETF (NYSEArca: XBI), one of the largest biotech ETFs, has already notched some impressive year-to-date returns, but XBI’s…
Evaluating the Biotech ETF Rally
The SPDR S&P Biotech ETF (NYSEArca: XBI), one of the largest biotech ETFs, is getting in on the sector’s resurgence. XBI, an…
Biotech ETF Investing is Hot, Can Get Hotter
Up more than 42% year-to-date, the SPDR S&P Biotech ETF (NYSEArca: XBI), one of the largest biotechnology ETFs, is one of this…